Skip to main
TFX

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 29%
Hold 57%
Sell 0%
Strong Sell 0%

Bulls say

Teleflex Inc. demonstrates a favorable outlook due to anticipated stronger revenue growth, margin expansion, and the potential for accretive acquisitions. The company's focus on its Interventional business, particularly in cardiology, is expected to drive mid-single-digit organic growth, bolstered by recent market share gains following a competitor's exit. Additionally, planned cost reduction efforts are projected to enhance operating margins and support double-digit earnings growth, further solidifying Teleflex's financial position.

Bears say

Teleflex Inc. has faced downward revisions in its revenue forecasts, indicating an organic revenue growth rate of 2.1%, which is below the market expectations of approximately 2.7%, contributing to a negative outlook. The company is grappling with specific weaknesses in its Interventional and Interventional Urology segments, driven by lower order rates for intra-aortic balloon pumps (IABPs) and ongoing pressures in the UroLift system, posing significant growth challenges. Additionally, risks associated with larger acquisitions and the potential dilution of earnings per share (EPS) further underscore the concerns regarding future profitability and market position.

Teleflex (TFX) has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 29% recommend Buy, 57% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 7 analysts, Teleflex (TFX) has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $139, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $139, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.